InsiderTrades.com logo

BRTX Insider Trading

Insider Ownership Percentage: 30.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

BioRestorative Therapies Insider Trading History Chart

This chart shows the insider buying and selling history at BioRestorative Therapies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioRestorative Therapies Share Price & Price History

Current Price: $1.11
Price Change: ▲ Price Increase of +0.03 (2.78%)
As of 12/4/2025 04:59 PM ET

This chart shows the closing price history over time for BRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioRestorative Therapies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2023Dale BroadrickMajor ShareholderBuy1,000$2.80$2,800.00306,073View SEC Filing Icon  
7/25/2023Lance AlstodtCEOBuy4,200$2.44$10,248.00184,418View SEC Filing Icon  
3/31/2023Francisco SilvaVPBuy747$3.56$2,659.32159,690View SEC Filing Icon  
2/22/2023Dale BroadrickMajor ShareholderBuy6,000$2.86$17,160.00305,073View SEC Filing Icon  
2/1/2023Lance AlstodtCEOBuy400$3.10$1,240.00187,321View SEC Filing Icon  
1/27/2023Lance AlstodtCEOBuy200$3.01$602.00186,921View SEC Filing Icon  
1/20/2023Lance AlstodtCEOBuy200$3.13$626.00186,721View SEC Filing Icon  
1/18/2023Lance AlstodtCEOBuy400$3.11$1,244.00186,521View SEC Filing Icon  
1/9/2023Lance AlstodtCEOBuy100$3.08$308.00186,121View SEC Filing Icon  
12/23/2022Lance AlstodtCEOBuy300$3.01$903.00186,021View SEC Filing Icon  
12/7/2022Lance AlstodtCEOBuy1,800$2.99$5,382.00185,721View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioRestorative Therapies (OTCMKTS:BRTX)

69.38% of BioRestorative Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BioRestorative Therapies Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/8/2023Cambridge Investment Research Advisors Inc.28,050$77K0.0%+22.0%0.768%Search for SEC Filing on Google Icon
5/12/2022Ayrton Capital LLC77,762$0.41M0.5%-31.0%2.144%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioRestorative Therapies logo
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Read More on BioRestorative Therapies

Today's Range

Now: $1.11
Low: $1.05
High: $1.17

50 Day Range

MA: $1.41
Low: $1.04
High: $1.67

52 Week Range

Now: $1.11
Low: $0.98
High: $2.55

Volume

32,200 shs

Average Volume

189,150 shs

Market Capitalization

$9.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.18